Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 13,241 | 11,134 | 10,682 | 11,463 | 13,265 |
| Cost of Goods | 6,617 | 4,737 | 5,305 | 4,625 | 5,242 |
| Gross Profit | 6,624 | 6,397 | 5,377 | 6,838 | 8,023 |
| Operating Expenses | 11,450 | 11,739 | 16,395 | 16,316 | 21,027 |
| Operating Income | -4,209 | -4,605 | -10,713 | -8,853 | -12,762 |
| Interest Expense | 1,428 | 1,487 | 1,704 | 3,688 | 3,572 |
| Other Income | 129 | 14,160 | 65 | 5 | 32 |
| Pre-tax Income | -5,508 | 8,068 | -12,352 | -12,536 | -16,302 |
| Income Tax | 284 | N/A | N/A | 0 | N/A |
| Net Income Continuous | -5,792 | 8,068 | -12,352 | -12,536 | -16,302 |
| Net Income | $-5,792 | $8,068 | $-12,352 | $-12,536 | $-16,302 |
| EPS Basic Total Ops | -0.10 | 0.15 | -0.21 | -0.23 | -0.36 |
| EPS Basic Continuous Ops | -0.10 | 0.15 | -0.20 | -0.23 | -0.36 |
| EPS Diluted Total Ops | -0.10 | 0.11 | -0.21 | -0.23 | -0.36 |
| EPS Diluted Continuous Ops | -0.10 | 0.11 | -0.20 | -0.23 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.10 | 0.11 | -0.23 | N/A | N/A |
| EBITDA(a) | $-3,861 | $-4,224 | $-10,258 | $-8,209 | $-12,026 |